🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Removal

According to TikTok, the platform has taken down violative content and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of weight loss, glowing reviews and detailed instructions for preparing or administering at home.

Within minutes of joining one community, a seller shared contact information, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has already seen individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially serious medical dangers”.